178 related articles for article (PubMed ID: 10917133)
1. Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer.
Renkonen-Sinisalo L; Aarnio M; Mecklin JP; Järvinen HJ
Cancer Detect Prev; 2000; 24(2):137-42. PubMed ID: 10917133
[TBL] [Abstract][Full Text] [Related]
2. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members.
Watson P; Lin KM; Rodriguez-Bigas MA; Smyrk T; Lemon S; Shashidharan M; Franklin B; Karr B; Thorson A; Lynch HT
Cancer; 1998 Jul; 83(2):259-66. PubMed ID: 9669808
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of colorectal cancer in families with hereditary nonpolyposis colorectal cancer].
Bernstein IT; Bisgaard ML; Myrhøj T
Ugeskr Laeger; 2003 Jan; 165(3):221-5. PubMed ID: 12555703
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer.
Engel C; Rahner N; Schulmann K; Holinski-Feder E; Goecke TO; Schackert HK; Kloor M; Steinke V; Vogelsang H; Möslein G; Görgens H; Dechant S; von Knebel Doeberitz M; Rüschoff J; Friedrichs N; Büttner R; Loeffler M; Propping P; Schmiegel W;
Clin Gastroenterol Hepatol; 2010 Feb; 8(2):174-82. PubMed ID: 19835992
[TBL] [Abstract][Full Text] [Related]
5. [Hereditary colorectal cancer].
Bernstein IT; Bülow S
Ugeskr Laeger; 2005 Oct; 167(44):4159-63. PubMed ID: 16266567
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic characteristics of hereditary non-polyposis colorectal cancer by the Amsterdam criteria: an Asian perspective.
Chew MH; Koh PK; Ng KH; Lim JF; Ho KS; Ooi BS; Tang CL; Eu KW
ANZ J Surg; 2008 Jul; 78(7):556-60. PubMed ID: 18593409
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations in patients with hereditary nonpolyposis colorectal cancer.
Tomoda H; Baba H; Oshiro T
J Surg Oncol; 1996 Apr; 61(4):262-6. PubMed ID: 8627995
[TBL] [Abstract][Full Text] [Related]
8. [Hereditary predisposition of colorectal cancer and prevalence of hereditary nonpolyposis colorectal cancer in general population of colorectal cancer patients in China].
Zhang YZ; Sheng JQ; Li SR; Wu ZT
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2995-3000. PubMed ID: 16324388
[TBL] [Abstract][Full Text] [Related]
9. Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients.
You JF; Hsieh LL; Changchien CR; Chen JS; Chen JR; Chiang JM; Yeh CY; Hsieh PS; Fan CW; Liu CT; Tang R
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4244-50. PubMed ID: 16857798
[TBL] [Abstract][Full Text] [Related]
10. A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers.
Vasen HF; van Ballegooijen M; Buskens E; Kleibeuker JK; Taal BG; Griffioen G; Nagengast FM; Menko FH; Meera Khan P
Cancer; 1998 May; 82(9):1632-7. PubMed ID: 9576281
[TBL] [Abstract][Full Text] [Related]
11. Frequency and type of colorectal tumors in asymptomatic high-risk individuals in families with hereditary nonpolyposis colorectal cancer.
Ponz de Leon M; Della Casa G; Benatti P; Percesepe A; di Gregorio C; Fante R; Roncucci L
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):639-41. PubMed ID: 9681535
[TBL] [Abstract][Full Text] [Related]
12. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome.
Mecklin JP; Aarnio M; Läärä E; Kairaluoma MV; Pylvänäinen K; Peltomäki P; Aaltonen LA; Järvinen HJ
Gastroenterology; 2007 Oct; 133(4):1093-8. PubMed ID: 17919485
[TBL] [Abstract][Full Text] [Related]
13. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
[TBL] [Abstract][Full Text] [Related]
14. Pathology of hereditary non-polyposis colorectal cancer.
Jass JR; Smyrk TC; Stewart SM; Lane MR; Lanspa SJ; Lynch HT
Anticancer Res; 1994; 14(4B):1631-4. PubMed ID: 7979198
[TBL] [Abstract][Full Text] [Related]
15. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
16. Colorectal carcinoma in different age groups: a population-based investigation.
Fante R; Benatti P; di Gregorio C; De Pietri S; Pedroni M; Tamassia MG; Percesepe A; Rossi G; Losi L; Roncucci L; Ponz de Leon M
Am J Gastroenterol; 1997 Sep; 92(9):1505-9. PubMed ID: 9317073
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of patients with clinically diagnosed colorectal cancer and those detected by mass screening.
Colorectal Cancer Cooperating Group, Beijing Society of Gastroenterology
Chin J Dig Dis; 2005; 6(1):26-30. PubMed ID: 15667555
[TBL] [Abstract][Full Text] [Related]
18. Survival of patients with Stage III colon cancer is improved in hereditary non-polyposis colorectal cancer compared with sporadic cases. A Danish registry based study.
Brixen LM; Bernstein IT; Bülow S; Ehrnrooth E
Colorectal Dis; 2013 Jul; 15(7):816-23. PubMed ID: 23350633
[TBL] [Abstract][Full Text] [Related]
19. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance.
Brown GJ; St John DJ; Macrae FA; Aittomäki K
Gynecol Oncol; 2001 Mar; 80(3):346-9. PubMed ID: 11263929
[TBL] [Abstract][Full Text] [Related]
20. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population.
Hata K; Watanabe T; Kazama S; Suzuki K; Shinozaki M; Yokoyama T; Matsuda K; Muto T; Nagawa H
Br J Cancer; 2003 Oct; 89(7):1232-6. PubMed ID: 14520452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
